Literature DB >> 25251969

Characterization of C60 fullerene complexation with antibiotic doxorubicin.

Yu I Prylutskyy1, M P Evstigneev, I S Pashkova, D Wyrzykowski, A Woziwodzka, G Gołuński, J Piosik, V V Cherepanov, U Ritter.   

Abstract

The aim of this paper was to provide the physico-chemical characterization of a key process leading to amplification of the antitumor effect of antibiotic Doxorubicin (Dox) in vivo and in vitro and occurring at the molecular level through complexation with C60 fullerene. A wide range of physico-chemical tools was used such as UV/Vis and NMR spectroscopies, atomic force microscopy, isothermal titration calorimetry and zeta-potential methods. The unusual thermodynamic behavior of the complexation process was reported, featuring unexpected and, to a certain extent, contradictory experimental observations. The explanation of the obtained results was proposed resulting in creation of a general view on aromatic drug binding with C60 fullerene. Based on these results some important practical outcomes for anticancer therapy were formulated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25251969     DOI: 10.1039/c4cp03367a

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  9 in total

1.  C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes.

Authors:  Marina Yu Skorkina; Evgenia A Sladkova; Elena A Shamray; Olga V Cherkashina; Maxim P Evstigneev; Anatoly S Buchelnikov; Yuriy I Prylutskyy; Uwe Ritter
Journal:  Eur Biophys J       Date:  2015-06-14       Impact factor: 1.733

Review 2.  Nanoantibiotics: Functions and Properties at the Nanoscale to Combat Antibiotic Resistance.

Authors:  M Mustafa Mamun; Adeola Julian Sorinolu; Mariya Munir; Eric P Vejerano
Journal:  Front Chem       Date:  2021-05-13       Impact factor: 5.221

3.  Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.

Authors:  Svitlana V Prylutska; Larysa M Skivka; Gennadiy V Didenko; Yuriy I Prylutskyy; Maxim P Evstigneev; Grygoriy P Potebnya; Rostyslav R Panchuk; Rostyslav S Stoika; Uwe Ritter; Peter Scharff
Journal:  Nanoscale Res Lett       Date:  2015-12-29       Impact factor: 4.703

4.  C60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes.

Authors:  Larysa M Skivka; Svitlana V Prylutska; Mariia P Rudyk; Nataliia M Khranovska; Ievgeniia V Opeida; Vasyl V Hurmach; Yuriy I Prylutskyy; Leonid F Sukhodub; Uwe Ritter
Journal:  Cancer Nanotechnol       Date:  2018-10-31

5.  Interactions of newly synthesized platinum nanoparticles with ICR-191 and their potential application.

Authors:  Agnieszka Borowik; Rafal Banasiuk; Natalia Derewonko; Michal Rychlowski; Marta Krychowiak-Masnicka; Dariusz Wyrzykowski; Magdalena Ziabka; Anna Woziwodzka; Aleksandra Krolicka; Jacek Piosik
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

6.  A Novel Nanoconjugate of Landomycin A with C60 Fullerene for Cancer Targeted Therapy: In Vitro Studies.

Authors:  V Bilobrov; V Sokolova; S Prylutska; R Panchuk; O Litsis; V Osetskyi; M Evstigneev; Yu Prylutskyy; M Epple; U Ritter; J Rohr
Journal:  Cell Mol Bioeng       Date:  2018-08-15       Impact factor: 2.321

7.  A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity.

Authors:  Svitlana Prylutska; Svitlana Politenkova; Kateryna Afanasieva; Volodymyr Korolovych; Kateryna Bogutska; Andriy Sivolob; Larysa Skivka; Maxim Evstigneev; Viktor Kostjukov; Yuriy Prylutskyy; Uwe Ritter
Journal:  Beilstein J Nanotechnol       Date:  2017-07-20       Impact factor: 3.649

8.  Synergy of Chemo- and Photodynamic Therapies with C60 Fullerene-Doxorubicin Nanocomplex.

Authors:  Anna Grebinyk; Svitlana Prylutska; Oksana Chepurna; Sergii Grebinyk; Yuriy Prylutskyy; Uwe Ritter; Tymish Y Ohulchanskyy; Olga Matyshevska; Thomas Dandekar; Marcus Frohme
Journal:  Nanomaterials (Basel)       Date:  2019-10-30       Impact factor: 5.076

9.  The Impact of Fullerenes as Doxorubicin Nano-Transporters on Metallothionein and Superoxide Dismutase Status in MCF-10A Cells.

Authors:  Natalia Zaręba; Klaudia Więcławik; Rene Kizek; Bozena Hosnedlova; Marta Kepinska
Journal:  Pharmaceutics       Date:  2022-01-02       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.